BFRI vs CLVS

Comparison between Biofrontera Inc (BFRI, Company) and (CLVS, Company).

BFRI vs CLVS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BFRI(COMPANY)	CLVS(COMPANY)
Market Cap	$12M	$12M
Max Drawdown	99.79%	N/A
Sharpe Ratio	0.90	N/A
5Y Beta	1.02	N/A
Industry	Drug Manufacturers - Specialty & Generic	N/A
P/E Ratio	-0.98	-0.04
Forward P/E	13.64	N/A
Debt to Equity	0.00%	769.53%
Free Cash Flow Yield	-79.55%	N/A
P/S Ratio	N/A	0.09
P/B Ratio	N/A	-0.03

Market Cap

BFRI

$12M

Winner

CLVS

$12M

Max Drawdown

BFRI

99.79%

CLVS

N/A

Sharpe Ratio

BFRI

0.90

CLVS

N/A

5Y Beta

BFRI

1.02

CLVS

N/A

Industry

BFRI

Drug Manufacturers - Specialty & Generic

CLVS

N/A

P/E Ratio

Winner

BFRI

-0.98

CLVS

-0.04

Forward P/E

BFRI

13.64

CLVS

N/A

Debt to Equity

Winner

BFRI

0.00%

CLVS

769.53%

Free Cash Flow Yield

BFRI

-79.55%

CLVS

N/A

P/S Ratio

BFRI

N/A

CLVS

0.09

P/B Ratio

BFRI

N/A

CLVS

-0.03

BFRI vs CLVS - Historical Returns

Returns include dividend reinvestment.

Period	BFRI	CLVS
1 month	+24.23%	N/A
3 months	+13.63%	N/A
6 months	+29.78%	N/A
1 year	+51.87%	N/A
5 years(CAGR)	-62.06%	N/A
Max(CAGR)	-62.06%	N/A

BFRI

+24.23%

CLVS

N/A

BFRI

+13.63%

CLVS

N/A

BFRI

+29.78%

CLVS

N/A

BFRI

+51.87%

CLVS

N/A

5Y(CAGR)

BFRI

-62.06%

CLVS

N/A

Max(CAGR)

BFRI

-62.06%

CLVS

N/A

BFRI vs CLVS - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

Year	BFRI	CLVS
2026	+36.14%	N/A
2025	-47.71%	N/A
2024	-61.07%	N/A
2023	-83.61%	+0.00%
2022	-86.75%	N/A
2021	+70.52%	N/A

BFRI vs CLVS Drawdown Comparison

The maximum drawdown for BFRI was -99.79%, occurring on May 30, 2025. This drawdown has not yet recovered.

The current BFRI drawdown is -99.63%.

Rank	BFRI	CLVS
#1	-99.79% Dec 23, 2021 - May 30, 2025	N/A
#2	-46.20% Nov 26, 2021 - Dec 21, 2021	N/A
#3	-43.99% Oct 29, 2021 - Nov 24, 2021	N/A
#4	-4.81% Dec 21, 2021 - Dec 23, 2021	N/A